Thymosin Alpha-1 (Tα1)
Typical Dosing Protocols (Research/Compounded Use Only) – Thymosin Alpha-1 (Tα1)
Common protocol: 1.6 mg subcutaneously twice weekly (e.g., Monday and Thursday). This is the most widely used maintenance dose for immune support.
Other reported ranges:
General wellness / preventive: 1.5 mg every 3–7 days or 2–3 times per week
Acute / intensive support: 1.5–3 mg daily for 5–14 days
Higher short-term: Up to 3–6.4 mg daily in some protocols (limited duration)
Reconstitution example (for a typical 10 mg vial): Add 2 mL bacteriostatic water (yielding ~5 mg/mL).
1.6 mg = 0.32 mL (32 units on U-100 insulin syringe)
3 mg = 0.6 mL (60 units)
Administration: Subcutaneous injection (abdomen or thigh). Morning or early evening is common.
Dosing is highly individualized based on goals (immune support, infection recovery, anti-aging) and response—consult a qualified healthcare provider experienced with peptides for personalized guidance. This is for informational purposes only.
Key Potential Benefits of Thymosin Alpha-1 (Tα1)
Powerful Immune Modulation and Restoration
Naturally derived from the thymus, it enhances, modifies, and restores immune function by promoting T-cell differentiation, maturation, and activation while preventing excessive apoptosis.
Balances Th1/Th2 responses, increases CD4+, CD8+, and CD4+/CD8+ ratios, and boosts natural killer (NK) cell activity for more effective immune surveillance.
Supports dendritic cell and macrophage function through toll-like receptor (TLR) pathways, improving antigen presentation and overall innate and adaptive immunity.
Enhanced Antiviral and Anti-Infection Defense
Strengthens responses against viral infections, including hepatitis B and C, by promoting interferon-γ, IL-2, and other cytokine production while helping clear infected cells.
Aids in reducing infection risk and severity in immunocompromised states, sepsis, and respiratory challenges by restoring lymphocytopenia and reversing T-cell exhaustion.
Improves vaccine responsiveness and supports faster recovery from acute or chronic infections through optimized immune coordination.
Support for Cancer Therapy and Anti-Tumor Activity
Acts as an immunotherapeutic adjunct by increasing MHC class I expression, enhancing tumor antigen recognition, and boosting CD8+ T-cell cross-priming for stronger anti-tumor immunity.
Helps counteract immunosuppression from chemotherapy or radiation, improving outcomes in models of melanoma, hepatocellular carcinoma, lung cancer, and others.
Exhibits direct anti-proliferative effects on certain tumor cells while promoting broader immunosurveillance and resilience during conventional treatments.
Anti-Inflammatory and Autoimmune Balance
Regulates cytokine profiles by increasing anti-inflammatory IL-10 and reducing excessive pro-inflammatory signals, helping maintain immune homeostasis.
Shows potential in supporting management of autoimmune conditions such as rheumatoid arthritis, multiple sclerosis, and systemic lupus erythematosus through balanced modulation rather than broad suppression.
Mitigates chronic inflammation and cytokine dysregulation, contributing to reduced tissue damage in inflammatory or stress-related states.
Improved Resilience in Aging and Immunocompromised States
Counters age-related thymic decline by stimulating thymic output and restoring youthful immune signaling patterns.
Enhances overall vitality, energy levels, and recovery capacity by optimizing immune-metabolic pathways and reducing susceptibility to opportunistic threats.
Supports better outcomes in conditions involving immune deficiency or dysregulation, promoting sustained physiological resilience.
Broader Tissue Protection and Recovery Support
Protects immune cells from steroid-induced apoptosis and supports cellular repair processes during stress or therapy.
Contributes to improved wound healing, reduced morbidity in critical care settings, and better metabolic regulation via pathways like AhR/IL-22.
Aids in maintaining balanced immune responses that support long-term healthspan and recovery from physical or environmental challenges.
